FDA Inspection 1068442 — RxCrossroads 3PL LLC
The FDA completed an inspection of RxCrossroads 3PL LLC on October 4, 2018 in Erlanger, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 4, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Erlanger, KY (United States)